Zobrazeno 1 - 10
of 63
pro vyhledávání: ''
Autor:
Maria Paola Ronchetti, Sara Cairoli, Fiammetta Piersigilli, Manjunath P. Pai, Bianca Maria Goffredo, Andrea Dotta, Iliana Bersani, Cinzia Auriti, Pietro Bagolan
Publikováno v:
Antimicrobial agents and chemotherapy, Vol. 65, no.4, p. e02494-20 [1-6] (2021)
Antimicrob Agents Chemother
Antimicrob Agents Chemother
Limited data are available on the most appropriate dosing, efficacy, and safety of micafungin in neonates and young infants with invasive candidiasis (IC). This study evaluated plasma levels, efficacy, and safety of micafungin at a dose of 8 mg/kg da
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fce0c87e0bdf212c558c2a6bb3a164d1
https://hdl.handle.net/2078.1/262529
https://hdl.handle.net/2078.1/262529
Autor:
Takuto Takahashi, Angela R. Smith, Mark N. Kirstein, James Fisher, Pamala A. Jacobson, Nathan Rubin
Publikováno v:
Antimicrob Agents Chemother
Voriconazole (VCZ) is an antifungal agent with wide inter- and intrapatient pharmacokinetic (PK) variability and narrow therapeutic index. Although obesity was associated with higher VCZ trough concentrations in adults, the impact of obesity had yet
Autor:
Sara Cairoli, Rosamaria Crisafulli, Tiziana Corsetti, Maria Paola Ronchetti, Bianca Maria Goffredo, Marco Falcone, Manjunath P. Pai, Andrea Dotta, Cinzia Auriti, Fiammetta Piersigilli
Publikováno v:
Antimicrobial Agents and Chemotherapy. 60:7333-7339
High doses of micafungin are advocated in neonates with systemic candidiasis, but limited pharmacokinetic (PK) and safety data are available to support their use. Eighteen preterm neonates and infants with systemic candidiasis, three of whom had meni
Autor:
Su jin Rhee, Seung Han Shin, Han Suk Kim, Jaeseong Oh, Seung-Hwan Lee, Seo Hyun Yoon, Kyung Sang Yu, Juyoung Lee, Yu Kyong Kim
Publikováno v:
Antimicrobial Agents and Chemotherapy. 63
Fluconazole is an antifungal agent with reported evidence for its prophylactic effect against systemic fungal infection in preterm infants. The aim of this study was to build a population pharmacokinetic model to evaluate the pharmacokinetic characte
Autor:
Grégory Jouvion, Fabrice Chrétien, Marjolaine Morgand, Sylvain Poirée, Blandine Rammaert, Romain Kania, Hugo Tran, Marie-Elisabeth Bougnoux, Olivier Lortholary
Publikováno v:
Antimicrobial Agents and Chemotherapy. 59:7857-7861
Invasive aspergillosis (IA) is a severe disseminated fungal disease that occurs mostly in immunocompromised patients. However, central nervous system IA, combining meningitis and skull base involvement, does not occur only in groups with classic risk
Publikováno v:
Antimicrobial Agents and Chemotherapy. 59:6816-6823
Pseudohyperphosphatemia due to an interaction between liposomal amphotericin B and the Beckman Coulter PHOSm assay occurs sporadically and remains underrecognized in clinical practice. This retrospective case-control study compares the incidences of
Survival in Patients with Candida glabrata Bloodstream Infection Is Associated with Fluconazole Dose
Autor:
Manjunath P. Pai, Gregory A. Eschenauer, Simon W. Lam, Kenneth P. Klinker, Twisha S Patel, Shu-Wen Lin, Peggy L. Carver
Robust pharmacodynamic indices that align fluconazole dose or exposure with outcomes in invasive candidiasis due to Candida glabrata remain elusive. The purpose of this retrospective multicenter study was to evaluate a cohort of 127 patients with C.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f3bc1b70ae6c65da3daca94c43a8569
https://europepmc.org/articles/PMC5971561/
https://europepmc.org/articles/PMC5971561/
Autor:
Yoshitsugu Miyazaki, Naoyuki Uchida, Hideki Araoka, Kazuya Ishiwata, Minoru Nagi, Yuki Taya, Akiko Yoneyama, Sho Ogura, Go Yamamoto, Hisashi Yamamoto, Daisuke Kaji, Aya Nishida, Shinsuke Takagi, Atsushi Wake, Hiroshi Shimazu, Muneyoshi Kimura, Satoshi Yamagoe, Shuichi Taniguchi, Shigeki Nakamura, Yuki Asano-Mori, Kosei Kageyama, Mitsuhiro Yuasa, Takashi Mitsuki
Publikováno v:
Antimicrobial Agents and Chemotherapy. 62
Limited data are available on micafungin breakthrough fungemia (MBF), fungemia that develops on administration of micafungin, in patients with hematological disorders. We reviewed medical and microbiological records of patients with hematological dis
Autor:
L. Beaumont, Dominique Grenet, Clément Picard, Véronique Boussaud, B. Douvry, Emmanuel Douez, Lucien Lecuyer, Romain Guillemain, Vincent Jullien, Eliane Billaud, Manon Launay, Antoine Roux
Publikováno v:
Antimicrobial Agents and Chemotherapy. 62
Appropriate exposure to posaconazole (PSZ) has been limited until the recent approval of the delayed-release oral tablet formulation. Our goal was to determine the exposure obtained by using the standard dose of 300 mg once a day in lung transplant (
Autor:
Anette Veringa, K. C. M. van der Elst, Greetje A. Kampinga, Daan J Touw, Roger J. M. Brüggemann, Jos G. W. Kosterink, Jan-Willem C. Alffenaar, Jan G. Zijlstra, Erwin M Jongedijk, J M Boonstra, T S van der Werf, Remco A. Koster
Publikováno v:
Antimicrobial Agents and Chemotherapy, 61, 12, pp. e01398-17-e01398-17
Antimicrobial Agents and Chemotherapy, 61, e01398-17-e01398-17
Antimicrobial Agents and Chemotherapy, 61(12):e01398-17. AMER SOC MICROBIOLOGY
Antimicrobial Agents and Chemotherapy, 61, e01398-17-e01398-17
Antimicrobial Agents and Chemotherapy, 61(12):e01398-17. AMER SOC MICROBIOLOGY
The estimated attributable mortality rate for invasive candidiasis (IC) in the intensive care unit (ICU) setting varies from 30 to 40%. Physiological changes in critically ill patients may affect the distribution and elimination of micafungin, and th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d67808d5f93f3ba619ce536e0eedcab
https://europepmc.org/articles/PMC5700342/
https://europepmc.org/articles/PMC5700342/